{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/PFE/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-21T00:20:11.685Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8278,"canonical_name":"PFIZER INC","cik":"0000078003","uei":null,"lei":null,"duns":null,"ticker":"PFE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":10,"clinical":100,"contracts":1,"open":1,"dol":2},"count":100,"timeline":[{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — BOURLA ALBERT — 2026-07-01","url_slug":"/sec/cik-0001595703/4/0001225208-26-006273","accession_number":"0001225208-26-006273","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000085","accession_number":"0000078003-26-000085","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000087","accession_number":"0000078003-26-000087","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000078","accession_number":"0000078003-26-000078","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000080","accession_number":"0000078003-26-000080","importance":30},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"DAMICO JENNIFER B.","title":"SVP & Controller","shares":2000,"price_per_share":25.7,"usd_value":51400,"security_title":"Common Stock","importance":35.0514},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04370054","excerpt":"[\"Hemophilia A\"]","importance":60},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07400653","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Diabetes, Type 2\",\"Type 2 Diabetes\"]","importance":60},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07400679","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy\"]","importance":30},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"Vyndaqel Capsules Special Investigation (ATTR-CM)","security_title":null,"status":"COMPLETED","accession_number":"NCT04108091","excerpt":"[\"Transthyretin (TTR) Amyloid Cardiomyopathy\"]","importance":25},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.","security_title":null,"status":"RECRUITING","accession_number":"NCT07152119","excerpt":"[\"Severe Alopecia Areata\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07013474","excerpt":"[\"COVID-19 Infection\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06698796","excerpt":"[\"Dermatomyositis\",\"Polymyositis\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07028853","excerpt":"[\"Metastatic Castration Sensitive Prostate Cancer (mCSPC)\",\"Hormone Sensitive Prostate Cancer\",\"Prostate Cancer\",\"Cancer of the Prostate\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06866405","excerpt":"[\"RSV Infection\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT05287126","excerpt":"[\"Ulcerative Colitis\"]","importance":45},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07563894","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07497854","excerpt":"[\"Migraine With or Without Aura\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.","security_title":null,"status":"RECRUITING","accession_number":"NCT06587035","excerpt":"[\"Dwarfism, Pituitary\"]","importance":25},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06647654","excerpt":"[\"Respiratory Syncytial Virus\",\"Respiratory Tract Diseases\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07160244","excerpt":"[\"Healthy\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05623020","excerpt":"[\"Multiple Myeloma\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07543380","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06679140","excerpt":"[\"COVID-19 SARS-CoV-2 Infection\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT05748171","excerpt":"[\"ACUTE LYMPHOBLASTIC LEUKEMIA\"]","importance":45},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT05355701","excerpt":"[\"Melanoma\",\"Non-Small-Cell Lung Cancer\",\"Thyroid Cancer\",\"Glioma\",\"Advanced Colorectal Cancer (Part 1)\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT06215118","excerpt":"[\"Multiple Myeloma\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07587697","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07556549","excerpt":"[\"Non-Small Cell Lung Cancer ALK-positive\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT06057402","excerpt":"[\"Multiple Myeloma\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05742217","excerpt":"[\"Relapse Multiple Myeloma\",\"Refractory Multiple Myeloma\"]","importance":25},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06873945","excerpt":"[\"Alopecia Areata\"]","importance":60},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07575906","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-05-12 16:12:04","kind":"contracts.award","reporter":"Department of Health and Human Services","title":"IGF::OT::IGF","security_title":"PFIZER INC","usd_value":68359693,"accession_number":null,"excerpt":null,"importance":70},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue","security_title":"PHASE2,PHASE3","status":"RECRUITING","accession_number":"NCT06989437","excerpt":"[\"Cachexia\",\"Metastatic Pancreatic Ductal Adenocarcinoma\"]","importance":60},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05568719","excerpt":"[\"Hemophilia A\",\"Hemophilia B\"]","importance":60},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT05070845","excerpt":"[\"Primary Immune Thrombocytopenia\"]","importance":45},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT07073820","excerpt":"[\"Pulmonary Hypertension\"]","importance":45},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B","security_title":"PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT03307980","excerpt":"[\"Hemophilia B\"]","importance":45},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension","security_title":"PHASE1,PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06137742","excerpt":"[\"Pulmonary Arterial Hypertension\"]","importance":45},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07269301","excerpt":"[\"Hepatic Impairment\",\"Healthy\"]","importance":30},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07315360","excerpt":"[\"Renal Impairment\",\"Healthy\"]","importance":30},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07567352","excerpt":"[\"Non-Small-Cell Lung\",\"ALK-positive Advanced NSCLC\",\"ALK-positive Non-small-cell Lung Cancer\",\"ALK-positive NSCLC\"]","importance":25},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06641466","excerpt":"[\"Menstrual Migraine\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07578649","excerpt":"[\"Endometrial Neoplasms\",\"Endometrial Cancer\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05156398","excerpt":"[\"Migraine\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07578636","excerpt":"[\"Healthy Male Volunteers\"]","importance":30},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT05538130","excerpt":"[\"Melanoma\",\"Glioma\",\"Thyroid Cancer\",\"Non-Small Cell Lung Cancer\",\"Malignant Neoplasms\",\"Brain Neoplasms\",\"Advanced or Metastatic Solid Tumors\",\"HGG\",\"LGG\",\"Low Grade Glioma\",\"High Grade Glioma\",\"Differentiated Thyroid Cancer\",\"NSCLC (Non-small Cell Lung Cancer)\"]","importance":30},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07542886","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting","security_title":null,"status":"RECRUITING","accession_number":"NCT05452941","excerpt":"[\"Pneumonia\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers","security_title":"PHASE1","status":"TERMINATED","accession_number":"NCT06870487","excerpt":"The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns","importance":80},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07318805","excerpt":"[\"Advanced Breast Cancer\",\"Metastatic Breast Cancer (HR+/ HER2-)\",\"Colorectal Cancer\",\"Metastatic Colorectal Adenocarcinoma\",\"Triple Negative Breast Cancer\"]","importance":30},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07575945","excerpt":"[\"Healthy Participant\"]","importance":30},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children","security_title":"PHASE3","status":"COMPLETED","accession_number":"NCT05634811","excerpt":"[\"Lyme Disease\"]","importance":70},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT02319837","excerpt":"[\"Hormone Sensitive Prostate Cancer\",\"Prostate Cancer\",\"Cancer of the Prostate\"]","importance":60},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05611801","excerpt":"[\"Hemophilia A\",\"Hemophilia B\"]","importance":60},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07573462","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"Consistency of Response With Rimegepant in Acute Treatment of Migraine","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06898047","excerpt":"[\"Migraine\"]","importance":25},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.","security_title":"PHASE4","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05295290","excerpt":"[\"Myocarditis\"]","importance":25},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.","security_title":"PHASE1,PHASE2","status":"TERMINATED","accession_number":"NCT05896163","excerpt":"Business/Administrative decision to pursue other programs/assets within the oncology portfolio. Not due to any detected safety signals or requests from regulatory authorities.","importance":80},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07226882","excerpt":"[\"Lyme Borreliosis\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06807268","excerpt":"[\"Eczema\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07062965","excerpt":"[\"Breast Cancer\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About mRNA Vaccines Against Influenza in Adults","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT07431853","excerpt":"[\"Healthy Adults\"]","importance":45},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of How the Medicine Called \"Etrasimod\" Works in Children With the Gut Disease Called Ulcerative Colitis","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT07470879","excerpt":"[\"Colitis, Ulcerative\"]","importance":45},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)","security_title":"PHASE1,PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06125522","excerpt":"[\"Breast Cancer\"]","importance":45},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"PF-07104091 as a Single Agent and in Combination Therapy","security_title":"PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04553133","excerpt":"[\"Small Cell Lung Cancer\",\"Ovarian Cancer\",\"Breast Cancer\"]","importance":45},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07391761","excerpt":"[\"Refractory Multiple Myeloma (RRMM)\"]","importance":25},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07235397","excerpt":"[\"Respiratory Syncytial Virus Infections\"]","importance":25},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context","security_title":"NA","status":"RECRUITING","accession_number":"NCT06487078","excerpt":"[\"ALK+ Non-Small-Cell Lung Carcinoma\"]","importance":25},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06551324","excerpt":"[\"Metastatic Castrate Resistant Prostate Cancer (mCRPC)\"]","importance":60},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07508228","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT03460977","excerpt":"[\"Metastatic Castration Resistant Prostate Cancer (mCRPC)\",\"Small Cell Lung Cancer (SCLC)\",\"Follicular Lymphoma (FL)\"]","importance":30},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Pfizer","title":"Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant","security_title":null,"status":"RECRUITING","accession_number":"NCT05046613","excerpt":"[\"Migraine\"]","importance":25},{"ts":"2026-05-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults","security_title":"PHASE1,PHASE2","status":"TERMINATED","accession_number":"NCT05703607","excerpt":"Strategic decision made by the company","importance":80},{"ts":"2026-05-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT06977581","excerpt":"[\"Asthma\"]","importance":45},{"ts":"2026-05-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07261371","excerpt":"[\"Healthy Volunteer\"]","importance":30},{"ts":"2026-05-01","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT05441215","excerpt":"[\"Healthy Participants\"]","importance":30},{"ts":"2026-04-30","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Vaccine Against E Coli in Healthy Adults","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07122986","excerpt":"[\"Healthy Participants\"]","importance":30},{"ts":"2026-04-29","kind":"clinical.trial","reporter":"Pfizer","title":"To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults","security_title":"PHASE1,PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05805826","excerpt":"[\"Clostridoides Difficile Associated Disease\"]","importance":45},{"ts":"2026-04-29","kind":"clinical.trial","reporter":"Pfizer","title":"A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.","security_title":"PHASE2","status":"RECRUITING","accession_number":"NCT07228390","excerpt":"[\"Hidradenitis Suppurativa\"]","importance":45},{"ts":"2026-04-29","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy","security_title":null,"status":"COMPLETED","accession_number":"NCT06393465","excerpt":"[\"Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)\"]","importance":25},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07029828","excerpt":"[\"Severe Alopecia Areata\"]","importance":60},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How a New Pneumococcal Vaccine Works in Infants","security_title":"PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06524414","excerpt":"[\"Pneumococcal Disease\"]","importance":45},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany","security_title":null,"status":"RECRUITING","accession_number":"NCT07494656","excerpt":"[\"ATTR-CM (Transthyretin Amyloid Cardiomyopathy)\"]","importance":25},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06476665","excerpt":"[\"Acute Lymphocytic Leukemia\"]","importance":25},{"ts":"2026-04-27","kind":"clinical.trial","reporter":"Pfizer","title":"Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies","security_title":"PHASE1,PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04181788","excerpt":"[\"Advanced Malignancies\",\"Non-small-cell Lung Cancer\"]","importance":45},{"ts":"2026-04-27","kind":"clinical.trial","reporter":"Pfizer","title":"A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules","security_title":"PHASE2","status":"COMPLETED","accession_number":"NCT04440176","excerpt":"[\"Meningococcal Vaccine\"]","importance":45},{"ts":"2026-04-27","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-04-27","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000044","accession_number":"0000078003-26-000044","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — NORA JOHNSON SUZANNE M — 2026-04-27","url_slug":"/sec/cik-0001310264/4/0001225208-26-004662","accession_number":"0001225208-26-004662","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Gottlieb Scott — 2026-04-27","url_slug":"/sec/cik-0001411359/4/0001225208-26-004663","accession_number":"0001225208-26-004663","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"4","title":"4 — Desmond-Hellmann Susan — 2026-04-27","url_slug":"/sec/cik-0001507911/4/0001225208-26-004658","accession_number":"0001225208-26-004658","importance":30},{"ts":"2026-04-27","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07552779","excerpt":"[\"Coronavirus Disease 2019\",\"Coronavirus Disease 2019 (COVID-19)\",\"COVID-19 (Coronavirus Disease 2019)\",\"Upper Respiratory Tract Infections\",\"Respiratory Tract Infection\",\"Respiratory Tract Diseases\",\"COVID-19\",\"COVID-19 Infection\",\"COVID-19 SARS-CoV-2 Infection\",\"Pneumonia\",\"Lung Diseases\"]","importance":30},{"ts":"2026-04-24","kind":"clinical.trial","reporter":"Pfizer","title":"MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma","security_title":"PHASE2","status":"TERMINATED","accession_number":"NCT05090566","excerpt":"A business decision was made by Pfizer to terminate the study and not proceed with the Phase 2 expansion of this study. The reason for study termination is not due to any safety concerns or requests from regulatory authorities.","importance":80},{"ts":"2026-04-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07470866","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies","security_title":"PHASE1","status":"TERMINATED","accession_number":"NCT06974734","excerpt":"The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns","importance":80},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07508241","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Drug Interaction\"]","importance":30},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07455240","excerpt":"[\"Healthy Participant\"]","importance":30},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"Phase 1 Study of PF-08046033 in Advanced Solid Tumors","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07519655","excerpt":"[\"Non-Small-Cell Lung\",\"Esophageal Cancer\",\"Cutaneous Melanoma\"]","importance":30},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07519135","excerpt":"[\"Healthy\"]","importance":30}]}